By Aranya Jain
♦ Max Fisher speculates on how the US will react to Syria’s use of chemical weapons – large changes in policy are unlikely – while Geoff Dyer examines the reasons behind the uncertainty of the US response.
♦ Genes isolated directly from humans are no longer patentable, as the US supreme court has ruled that only synthetic versions of DNA, known as complementary DNA, can be patented. New access to previously company owned DNA may improve and lessen the cost of treatment, but the loss of patents may also cause a loss of incentive for companies to conduct new research. For those who have more time this weekend, The Immortal Life of Henrietta Lacks is a novel that grapples with these issues, examining the legacy of a woman whose DNA has become one of the most important tools in medicine, and yet has remained virtually anonymous, never receiving the rights to her own genes.
♦On a lighter note, the US navy will soon stop shouting its communications as messages no longer have to be written in all capital letters.
♦Foreign Policy brings you the fashion highlights from the Iranian election campaigns.
♦And if you have a spare moment, Satan has a few words to say on the Murdoch divorce.
- •Contact us
- •About us
- •Advertise with the FT
- •Terms & conditions
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.